Design, synthesis and pharmacological evaluation of new acyl sulfonamides as potent and selective Bcl-2 inhibitors

被引:15
作者
Liu, Xiaohua [1 ,2 ]
Zhang, Yu [3 ]
Huang, Wenjing [3 ]
Tan, Wenfu [3 ]
Zhang, Ao [1 ,2 ,4 ]
机构
[1] Univ Chinese Acad Sci, SIMM, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
[2] Univ Chinese Acad Sci, State Key Lab Drug Res, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
[3] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China
[4] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
关键词
Bcl-2; Bcl-xL; Sulfonamide; Navitoclax; Apoptosis; FAMILY; ANTAGONISTS; DISCOVERIES; PROTEINS; DOCKING;
D O I
10.1016/j.bmc.2017.12.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The antiapoptotic protein Bcl-2, overexpressed in many tumor cells, is an attractive target for potential small molecule anticancer drug discovery. Herein, we report a different structural modification approach on ABT-263 by merging the piperazinyl-phenyl fragment into a bicyclic framework leading to a series of novel analogues, among which tetrahydroisoquinoline 13 was nearly equally potent against Bcl-2 as ABT-263. Further SAR in the P4-interaction pocket affored the difluoroazetidine substituted analogue 55, which retained good Bcl-2 activity with improved Bcl-2/Bcl-xL selectivity. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:443 / 454
页数:12
相关论文
共 25 条
[1]   From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors [J].
Ashkenazi, Avi ;
Fairbrother, Wayne J. ;
Leverson, Joel D. ;
Souers, Andrew J. .
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (04) :273-284
[2]   Studies leading to potent, dual inhibitors of bcl-2 and Bcl-xL [J].
Bruncko, Milan ;
Oost, Thorsten K. ;
Belli, Barbara A. ;
Ding, Hong ;
Joseph, Mary K. ;
Kunzer, Aaron ;
Martineau, Darlene ;
McClellan, William J. ;
Mitten, Michael ;
ng, Shi-Chu Ng ;
Nimmer, Paul M. ;
Oltersdorf, Tilman ;
Park, Cheol-Min ;
Petros, Andrew M. ;
Shoemaker, Alexander R. ;
Song, Xiaohong ;
Wang, Xilu ;
Wendt, Michael D. ;
Zhang, Haichao ;
Fesik, Stephen W. ;
Rosenberg, Saul H. ;
Elmore, Steven W. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) :641-662
[3]   5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII [J].
Cvijetic, Ilija N. ;
Tanc, Muhammet ;
Juranic, Ivan O. ;
Verbic, Tatjana Z. ;
Supuran, Claudiu T. ;
Drakulic, Branko J. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (15) :4649-4659
[4]   Cell death: Critical control points [J].
Danial, NN ;
Korsmeyer, SJ .
CELL, 2004, 116 (02) :205-219
[5]   Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies [J].
Delbridge, Alex R. D. ;
Grabow, Stephanie ;
Strasser, Andreas ;
Vaux, David L. .
NATURE REVIEWS CANCER, 2016, 16 (02) :99-109
[6]   Synthesis and anti-inflammatory evaluation of new sulfamoylheterocarboxylic derivatives [J].
Diaz, JA ;
Morante, ME ;
Vega, S ;
Darias, V ;
Abdala, S ;
Delgado, L ;
Heras, BD ;
Villar, A ;
Vivas, JM .
ARCHIV DER PHARMAZIE, 1996, 329 (05) :229-238
[7]  
Elmore SW, 2013, NAT MED, V19, P2020
[8]   Imaging Cellular Distribution of Bcl Inhibitors Using Small Molecule Drug Conjugates [J].
Giedt, Randy J. ;
Sprachman, Melissa M. ;
Yang, Katherine S. ;
Weissleder, Ralph .
BIOCONJUGATE CHEMISTRY, 2014, 25 (11) :2081-2085
[9]   Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity [J].
Hennessy, Edward J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (09) :2105-2114
[10]   Melanin-concentrating hormone receptor 1 antagonists: Synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives [J].
Kasai, Shizuo ;
Kamaura, Masahiro ;
Kamata, Makoto ;
Aso, Kazuyoshi ;
Ogino, Hitomi ;
Nakano, Yoshihide ;
Watanabe, Kaoru ;
Kaisho, Tomoko ;
Tawada, Michiko ;
Nagisa, Yasutaka ;
Takekawa, Shiro ;
Kato, Koki ;
Suzuki, Nobuhiro ;
Ishihara, Yuji .
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (21) :6261-6273